Detecting pioglitazone use and risk of cardiovascular events using electronic health record data in a large cohort of Chinese patients with type 2 diabetes

BACKGROUND: Pioglitazone may have a protective effect against cardiovascular disease risk among type 2 diabetes (T2D) patients, but evidence from China is lacking. This study investigated the association using electronic health records (EHR) data from a Chinese cohort of T2D patients. METHODS: All T...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Shumei, Dong, Xiao, Zhang, Xin, Jing, Shenqi, Zhang, Xiaoliang, Xu, Tingyu, Wang, Li, Du, Xianglin, Xu, Hua, Liu, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850402/
https://www.ncbi.nlm.nih.gov/pubmed/30597747
http://dx.doi.org/10.1111/1753-0407.12894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850402/
https://www.ncbi.nlm.nih.gov/pubmed/30597747
http://dx.doi.org/10.1111/1753-0407.12894

Ejemplares similares